Abstract
A critical appraisal and clinical application of Lee AYY, Levin MN, Bake RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146-153. doi: 10.1056/NEJMoa025313
DOI
10.22237/crp/1493251200
Recommended Citation
Choi S. Low molecular-weight heparin is better than warfarin for prevention of recurrent venous thromboembolism in cancer patients. Clin. Res. Prac. 2017;3(1):eP1068. doi: 10.22237/crp/1493251200
Included in
Hematology Commons, Medical Education Commons, Oncology Commons, Translational Medical Research Commons
